Related Experiment Video

Updated: Jul 3, 2025

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
12:55

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells

Published on: October 10, 2017

9.0K

Update on the Role of Colchicine in Cardiovascular Disease

Darcy Banco1, Mohammad Mustehsan1, Binita Shah2,3

  • 1Leon H Charney Division of Cardiology, NYU Grossman School of Medicine, New York, NY, 10016, USA.

Current Cardiology Reports
|February 10, 2024
PubMed
Abstract

Insights

Colchicine, an anti-inflammatory drug, effectively prevents cardiovascular events by targeting inflammation in patients with coronary artery disease. Ongoing research explores its optimal use in various at-risk populations.

Area of Science:

  • Cardiology
  • Pharmacology
  • Inflammation Research

Background:

  • Coronary artery disease (CAD) involves atherosclerotic plaque progression and rupture, driven by inflammatory pathways.
  • Inflammation plays a critical role in the pathogenesis of acute coronary syndromes and cardiovascular events.
  • Targeting inflammation presents a therapeutic strategy for preventing adverse cardiovascular outcomes.

Purpose of the Study:

  • To review the efficacy of colchicine in preventing cardiovascular events in patients with or at risk for coronary artery disease.
  • To elucidate the anti-inflammatory mechanisms of colchicine relevant to cardiovascular protection.
  • To discuss the potential expanded applications of colchicine in cardiovascular disease prevention.

Main Methods:

  • Review of clinical trials and scientific literature on colchicine's cardiovascular effects.
  • Analysis of colchicine's impact on inflammatory biomarkers (IL-1β, IL-6, CRP) and atherosclerotic plaque stability.
  • Evaluation of colchicine's efficacy in diverse patient cohorts, including chronic CAD and recent myocardial infarction.

Main Results:

  • Colchicine significantly reduces cardiovascular events by 31% in chronic CAD and 23% in recent myocardial infarction.
  • Colchicine targets the IL-1β/IL-6/CRP inflammatory pathway, mitigating plaque progression and rupture.
  • Evidence suggests colchicine's potential to prevent events post-major non-cardiac surgery by dampening inflammation.

Conclusions:

  • Colchicine is an effective anti-inflammatory therapy for preventing acute coronary syndromes and cardiovascular events in CAD patients.
  • Its anti-inflammatory properties warrant consideration for broader use in at-risk populations.
  • Further research is ongoing to define optimal colchicine use for cardiovascular event prevention.
Keywords:
Cardiovascular diseaseColchicineInflammationMyocardial infarctionPrevention

More Related Videos

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

12.3K
Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation08:53

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation

Published on: July 27, 2022

834

Related Concept Videos

Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
141
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.8K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
514
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
524
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
810
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
164